Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Miriam Sánchez-García"'
Autor:
Alejandra Albarrán-Sánchez, Claudia Ramírez-Rentería, Moisés Mercado, Miriam Sánchez-García, Corazón de Jesús Barrientos-Flores, Aldo Ferreira-Hermosillo
Publikováno v:
Therapeutic Advances in Endocrinology and Metabolism, Vol 13 (2022)
Introduction: Currently, only glucocorticoids have proved to impact adverse outcomes in COVID-19. However, their risk/benefit balance remains inconclusive and populations’ characteristics should be considered. Objective: The objective was to evalua
Externí odkaz:
https://doaj.org/article/44233bd1f7ac4d8ca28752a006852e57
Autor:
María, Bas-Zaragoza Juana, Concepción, Cáceres-Hernández, Monserrat, De Paco-López, Aurora, Garrido-Gómez, José, González-Guirao María, Ana, González-Martínez, del Carmen, Jiménez-Gea María, Teresa, Lax-Garnés María, Victoria, López-Moreno María, Victoria, Lorca-Cámara María, Rosa, Lozano-Magdalena Ana, Encarnación, Martínez-Martínez, Sara, Martínez-Zaragoza, Mercedes, Mellado-Gutiérrez, Raquel, Moreno-Martínez, Elena, Navarro-Domínguez, Rocío, Pérez-Méndez, Miriam, Sánchez-García, del Mar, Sánchez-González María, Carlos, Sánchez-Palomares José, Lucía, Tovar-Aullón, Verónica, Zamora-Romero, Molina-Salas, Yolanda, Romera-Guirado, Francisco José, García-Rubio, Ana, Pérez-Martín, Jaime Jesús, Zornoza-Moreno, Matilde
Publikováno v:
In Journal of Pediatric Nursing November-December 2024 79:52-58
Autor:
Miriam Sánchez-García, Etual Espinosa-Cárdenas, Claudia Ramírez-Rentería, Ernesto Sosa-Eroza, Moisés Mercado, Victoria Mendoza-Zubieta
Publikováno v:
Endocrine. 70:143-149
Purpose Treatment with dopamine agonists (DA) is highly effective in patients with prolactinomas. In selected patients, discontinuation of DA after several years of successful treatment is possible, however, hyperprolactinemia recurs in 60-80% of the
Publikováno v:
Growth hormoneIGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society. 64
The most frequent diagnosis underlying the finding of an elevated growth hormone (GH) and insulin-like growth factor-1 (IGF-1) is acromegaly due to a GH-secreting pituitary tumour. However, GH and IGF-1 levels can be discordant in patients with acrom
Autor:
Miriam Sánchez-García, Ernesto Sosa-Eroza, Victoria Mendoza-Zubieta, Etual Espinosa-Cárdenas, Claudia Ramírez-Rentería, Moisés Mercado
Publikováno v:
Endocrine. 71:263-264